21.09.2015 • News

French Court Partially Lifts Ban on BPA

French companies can now produce BPA-based products for export after the French Constitutional Council ruled the law was unconstitutional. The ruling by the country’s highest constitutional authority stated that the French law of December 24, 2012, which suspends the use of BPA, “unjustifiably restricts trade”.

At the same time, it upheld an existing restriction within France on BPA-based material used in contact with food, ruling that the remainder of the law was not unconstitutional. However, the authority conceded it did not have the competence to assess the law’s scientific merits.

Because of the split ruling, and the fact that the council did not assess the compatibility of the French law with existing EU regulations, trade organization PlasticsEurope will continue legal proceedings both with the French Council of State and at European level. It filed a case with the French authority in June this year, and argues that the law should be removed in its entirety.

“Given that the French court has repealed the ban on exports from France, and yet maintained the ban within France, necessitates immediate action at European level to resolve this very arbitrary situation,” said Jasmin Bird from PlasticsEurope’s PC/BPA-group. “The fact remains that leading independent scientific authorities worldwide such as the European Food Safety Authority (EFSA) have concluded that BPA-based food contact materials pose no risk to consumers.”

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read